Cargando…

NEW-ONSET ATRIAL FIBRILLATION DURING HOSPITALIZATION FOR COVID-19 PATIENTS WITHOUT PREEXISTING CARDIOVASCULAR DISEASE

Detalles Bibliográficos
Autores principales:	Wang, Suwei, Huang, Hu, Kolt, Benjamin, Jackson, Gretchen, Preininger, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091442/ http://dx.doi.org/10.1016/S0735-1097(21)04469-7

Ejemplares similares

COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

SEVERITY OF COVID-19 FURTHER INCREASES THE ODDS OF NEW-ONSET ATRIAL FIBRILLATION AND FLUTTER
por: Shah, Paras P., et al.
Publicado: (2022)

EFFECT OF TOCILIZUMAB ON NEW ONSET ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS: AN UMBRELLA REVIEW
por: Patel, Aman, et al.
Publicado: (2022)

PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19
por: Sanders, David, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS
por: Kattubadi, Ayeesha, et al.
Publicado: (2022)

ATRIAL FIBRILLATION IS ASSOCIATED WITH EARLY MORTALITY IN CRITICALLY ILL PATIENTS WITH COVID-19
por: Foster, Michael W., et al.
Publicado: (2022)

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
por: Limani, Saurabhkumar M., et al.
Publicado: (2023)

THE IMPACT OF ORAL ANTICOAGULANTS ON THE OUTCOMES OF COVID-19 PATIENTS WITH A HISTORY OF HF AND ATRIAL FIBRILLATION
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

IMPACT OF ATRIAL FIBRILLATION IN A PATIENT ADMITTED WITH COVID-19 INFECTION: A NATIONWIDE SAMPLE ANALYSIS
por: Ellis, John, et al.
Publicado: (2023)

CARDIOVASCULAR COMORBIDITIES PREDISPOSE TO CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19 INFECTION
por: Razipour, Shadi, et al.
Publicado: (2022)

ATRIAL ARRHYTHMIAS ASSOCIATED WITH INCREASED MORBIDITY AND MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19
por: Bailey, Som Aftabi, et al.
Publicado: (2021)

TRENDS IN LONG-TERM CARDIOVASCULAR-RELATED HOSPITAL ADMISSIONS AFTER COVID-19 HOSPITALIZATION
por: Fontana, Gregory Paul, et al.
Publicado: (2023)

CARDIOVASCULAR AND MORTALITY OUTCOMES IN ONCOLOGY PATIENTS HOSPITALIZED WITH COVID-19
por: Kwan, Jennifer, et al.
Publicado: (2021)

PRE-EXISTING CARDIOVASCULAR DISEASE, ACUTE KIDNEY INJURY, AND CARDIOVASCULAR OUTCOMES IN HOSPITALIZED BLACKS WITH COVID-19 INFECTION
por: Egbuche, Obiora, et al.
Publicado: (2021)

THROMBOEMBOLIC OUTCOMES IN HOSPITALIZED PATIENTS WITH UNDERLYING CARDIOVASCULAR DISEASE AND COVID-19
por: Khairani, Candrika, et al.
Publicado: (2021)

IN-HOSPITAL OUTCOMES AMONG COVID-19 PATIENTS WITH CANCER AND CARDIOVASCULAR DISEASE
por: Tehrani, David, et al.
Publicado: (2021)

CARDIOVASCULAR AND MORTALITY OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS STRATIFIED BY RACE AND ETHNICITY
por: Kwan, Jennifer, et al.
Publicado: (2021)

CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION AND HISTORY OF CANCER
por: Siddiqi, Hasan, et al.
Publicado: (2021)

CARDIOVASCULAR IMPACT OF COVID-19 AMONG HOSPITALIZED US ACTIVE-DUTY SERVICE MEMBERS
por: McClelland, Patton, et al.
Publicado: (2023)

EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)

HEALTH DISPARITIES INVOLVING HOSPITALIZATIONS AMONG COVID-19 VACCINATED CARDIOVASCULAR DISEASE PATIENTS INFECTED BY SARS-COV-2
por: Khodaverdi, M., et al.
Publicado: (2022)

IMPACT OF A LARGE-SCALE TELEMEDICINE NETWORK ON ALL-CAUSE AND CARDIOVASCULAR EMERGENCY AND HOSPITAL ADMISSIONS DURING THE COVID-19 PANDEMIC IN BRAZIL
por: Nascimento, Bruno Ramos, et al.
Publicado: (2021)

FOLLOW-UP OF HOSPITALIZED COVID-19 SURVIVORS: ASSESSMENT OF SHORT AND LONG-TERM CARDIOVASCULAR SEQUELAE AFTER SARS-COV-2 INFECTION
por: Birtolo, Lucia Ilaria, et al.
Publicado: (2022)

COVID-19 AND HEART: ASSESSMENT OF TROPONIN AND CARDIOVASCULAR COMORBIDITIES AS PROGNOSTIC MARKERS IN PATIENTS HOSPITALIZED FOR COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Pinesi, Henrique, et al.
Publicado: (2022)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

THE IMPACT OF THE COVID-19 PANDEMIC ON ACCESS TO CARDIOVASCULAR CARE LEADING TO INCREASED CARDIOVASCULAR MORTALITY
por: Kim, Yoo Jin, et al.
Publicado: (2022)

THE CONSEQUENCES OF THE LOCKDOWN ON CARDIOVASCULAR DISEASES
por: Aajal, Assia, et al.
Publicado: (2021)

ONSET OF THE COVID-19 PANDEMIC REDUCED ACTIVE TIME IN PATIENTS WITH IMPLANTED PACEMAKERS
por: Sommers, Nicholas, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

THE IMPACT OF TELEHEALTH ON OUTCOMES IN CARDIOVASCULAR PATIENTS
por: Cioci, Anthony, et al.
Publicado: (2022)

OUTCOMES OF COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASE
por: Vu, Chau N., et al.
Publicado: (2021)

THE IMPLICATIONS OF COVID-19 VACCINATION ON HOSPITALIZATIONS AND CLINICAL OUTCOMES
por: Case, Brian, et al.
Publicado: (2022)

COVID-19: RACIAL DISPARITY AND CARDIOVASCULAR COMORBIDITIES THAT PREDICT MORTALITY
por: Omeh, Demian Jideofor, et al.
Publicado: (2021)

PREVALENCE AND OUTCOMES OF CARDIOVASCULAR COMPLICATIONS AMONGST COVID-19 PATIENTS
por: Aedma, Surya Kiran, et al.
Publicado: (2021)

IMPACT OF COVID-19 ON CARDIOVASCULAR CLINICS: ARE WE READY FOR TELE-MEDICINE?
por: Mujtaba, Mustajab, et al.
Publicado: (2022)

CARDIOVASCULAR PATIENT OUTCOMES AND COMPLICATIONS AFTER SARS-COV-2 INFECTION
por: Khodaverdi, M., et al.
Publicado: (2022)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tj93dpogud1a97vo464a817u40